R07 PITUITARY
NDC 63479-1807, ADENOSINE TRIPHOSPHATE DISODIUM, AMMONIUM CARBONATE, SAFFRON, STRYCHNOS IGNATII SEED, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, STRYCHNOS NUX-VOMICA SEED, and VERATRUM ALBUM ROOT, solution, from Apex Energetics Inc..
- Product NDC
- 63479-1807
- Status
- Listed
- Labeler
- Apex Energetics Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1807 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADENOSINE TRIPHOSPHATE DISODIUM5 [hp_X]/mL
- AMMONIUM CARBONATE6 [hp_C]/mL
- SAFFRON1 [hp_Q]/mL
- STRYCHNOS IGNATII SEED7 [hp_C]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE7 [hp_C]/mL
- STRYCHNOS NUX-VOMICA SEED7 [hp_C]/mL
- VERATRUM ALBUM ROOT7 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63479-1807-1 | 63479180701 | 30 mL in 1 BOTTLE, GLASS (63479-1807-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63479-1807 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63479-1807 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63479-1807. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.